Does APIXABAN Cause Arteriosclerosis? 305 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 305 reports of Arteriosclerosis have been filed in association with APIXABAN (ELIQUIS). This represents 0.2% of all adverse event reports for APIXABAN.
305
Reports of Arteriosclerosis with APIXABAN
0.2%
of all APIXABAN reports
62
Deaths
253
Hospitalizations
How Dangerous Is Arteriosclerosis From APIXABAN?
Of the 305 reports, 62 (20.3%) resulted in death, 253 (83.0%) required hospitalization, and 127 (41.6%) were considered life-threatening.
Is Arteriosclerosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 305 reports have been filed with the FAERS database.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause Arteriosclerosis?
NILOTINIB (464)
ROSIGLITAZONE (436)
PREDNISONE (260)
DOXAZOSIN (242)
ALBUTEROL (238)
FLUTICASONE\SALMETEROL (236)
LEVOFLOXACIN (235)
BUDESONIDE (227)
TIOTROPIUM (224)
DUTASTERIDE (212)
Which APIXABAN Alternatives Have Lower Arteriosclerosis Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ